BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 28900986)

  • 21. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinicopathological classification and prognostic factors of gastrointestinal neuroendocrine neoplasms: an analysis of 119 cases].
    Ma X; Zhao W; Zhuang C; Wang X; Tu L; Wang M; Sun Y; Cao H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):997-1001. PubMed ID: 28900989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon.
    Kourie HR; Ghorra C; Rassy M; Kesserouani C; Kattan J
    Asian Pac J Cancer Prev; 2016; 17(5):2679-81. PubMed ID: 27268650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The diagnosis and treatment of G3 neuroendocrine tumors according to the new NCCN guideline].
    Liang Y; Yu XJ; Chen J
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):982-987. PubMed ID: 35399015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chinese expert consensus on gastroenteropancreatic neuroendocrine neoplasms (2022 edition)].
    Expert Committee on Neuroendocrine Neoplasms, Chinese Society of Clinical Oncology
    Zhonghua Zhong Liu Za Zhi; 2022 Dec; 44(12):1305-1329. PubMed ID: 36575783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuroendocrine neoplasia of the stomach : What is new?].
    Knösel T; Reiter C; Schubert-Fritschle G; Altendorf-Hofmann A; Kirchner T
    Pathologe; 2017 Mar; 38(2):98-104. PubMed ID: 28188377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-Up.
    Vanoli A; La Rosa S; Miceli E; Klersy C; Maragliano R; Capuano F; Persichella A; Martino M; Inzani F; Luinetti O; Di Sabatino A; Sessa F; Paulli M; Corazza GR; Rindi G; Bordi C; Capella C; Solcia E
    Neuroendocrinology; 2018; 107(2):114-126. PubMed ID: 29895024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms.
    Narayanan D; Mandal R; Hardin H; Chanana V; Schwalbe M; Rosenbaum J; Buehler D; Lloyd RV
    Endocr Pathol; 2020 Sep; 31(3):254-263. PubMed ID: 32388776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
    Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
    Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant Expression of Long Non Coding RNA HOTAIR and De-Regulation of the Paralogous 13 HOX Genes Are Strongly Associated with Aggressive Behavior of Gastro-Entero-Pancreatic Neuroendocrine Tumors.
    Di Mauro A; Scognamiglio G; Aquino G; Cerrone M; Liguori G; Clemente O; Di Bonito M; Cantile M; Botti G; Tafuto S; Tatangelo F
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34208964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspects regarding nomenclature, classification and pathology of neuroendocrine neoplasms of the digestive system - a review.
    Păun I; Becheanu G; Costin AI; Constantin VD; Mihai GM; Radu L; Iovan L; Vârcuş F
    Rom J Morphol Embryol; 2018; 59(3):673-678. PubMed ID: 30534804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3.
    Merola E; Falconi M; Rinke A; Staettner S; Krendl F; Partelli S; Andreasi V; Gress TM; Pascher A; Arsenic R; Doglioni C; Kaemmerer D; Wiedenmann B; Pavel ME
    Am J Surg; 2020 Aug; 220(2):284-289. PubMed ID: 32209239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
    Masui T; Ito T; Komoto I; Uemoto S;
    BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution.
    Yang M; Zeng L; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
    BMC Cancer; 2020 Sep; 20(1):906. PubMed ID: 32962649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastroenteric neuroendocrine neoplasms classification: comparison of prognostic models.
    Dolcetta-Capuzzo A; Villa V; Albarello L; Franchi GM; Gemma M; Scavini M; Di Palo S; Orsenigo E; Bosi E; Doglioni C; Manzoni MF
    Cancer; 2013 Jan; 119(1):36-44. PubMed ID: 22744914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of World Health Organization 2010 Classification for Gastroenteropancreatic Neuroendocrine Neoplasms with the Prognosis of Ovarian Neuroendocrine Neoplasms: Kansai Clinical Oncology Group-Protocol Review Committee/Intergroup Study.
    Kai K; Nasu K; Nishida H; Daa T; Shikama A; Shiozaki T; Kurakazu M; Yano M; Imamura Y; Tokunaga H; Tasaki K; Iida Y; Yamada Y; Morisawa H; Nakagawa S; Fujimoto E; Tsuruta T; Matsumoto H; Arakawa A; Nonaka M; Takano H; Ushiwaka T; Mori T; Ito K; Motohashi T; Teramoto N; Yamada T
    Neuroendocrinology; 2021; 111(4):320-329. PubMed ID: 32097950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population-based study.
    Zhang P; Wang W; Lu M; Zeng C; Chen J; Li E; Tan H; Wang W; Yu X; Tang Q; Zhao J; Shen L; Li J
    Cancer Med; 2018 Sep; 7(9):4361-4370. PubMed ID: 30062861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interpretation of updated international guidelines for diagnosis and treatment of gastroenter-opancreatic neuroendocrine neoplasms].
    Chen LH; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):843-848. PubMed ID: 34674457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexistence of superficial carcinogenesis of resident epithelium besides neuroendocrine neoplasm of the digestive tract.
    Kuwano H; Yokobori T; Ide M; Saeki H; Sohda M; Sakai M; Yoshida T; Kuriyama K; Ogata K; Ogawa H; Okada T; Miyazaki T; Takahashi S; Shirabe K
    Cancer Med; 2022 Feb; 11(4):983-992. PubMed ID: 35048546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience.
    Shen C; Chen H; Chen H; Yin Y; Han L; Chen J; Tang S; Yin X; Zhou Z; Zhang B; Chen Z
    BMC Gastroenterol; 2016 Sep; 16(1):111. PubMed ID: 27613657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.